APA (7th ed.) Citation

Rizzieri, D. A., Crout, C., Storms, R., Golob, J., Long, G. D., Gasparetto, C., . . . Chao, N. J. (2011). Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors. Cancer Investigation, 29(1), 56. https://doi.org/10.3109/07357907.2010.535055

Chicago Style (17th ed.) Citation

Rizzieri, David A., et al. "Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors." Cancer Investigation 29, no. 1 (2011): 56. https://doi.org/10.3109/07357907.2010.535055.

MLA (9th ed.) Citation

Rizzieri, David A., et al. "Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors." Cancer Investigation, vol. 29, no. 1, 2011, p. 56, https://doi.org/10.3109/07357907.2010.535055.